Ειδήσεις: BITO | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

29/03 10:34 defenseworld.net

Dynamic Advisor Solutions LLC Lowers Position in ProShares Bitcoin ETF $BITO

Dynamic Advisor Solutions ProShares Bitcoin ETF BITO institutional investor hedge fund position change

27/03 07:10 dev.to

Evidence & Judgment Why Science Alone Does Not Finish the Clinical Decision

heart failure CKD ACE inhibitor beta‑blocker patient preference guideline adherence

24/03 15:00 oregonlive.com

Dear Doctor: What are my risks when taking over-the-counter Prevacid for acid reflux daily?

OTC Prevacid acid reflux proton‑pump inhibitor H2 antagonist daily use symptom control

22/03 18:01 dev.to

Inside Taiwan CYBERSEC 2020: A Global Milestone in Cybersecurity Innovation

Taiwan CYBERSEC cybersecurity tech collaboration global innovation defense strategy

20/03 10:22 statnews.com

STAT+: Novartis picks up experimental breast cancer drug for $2B

Novartis breast cancer PI3K inhibitor Synnovation Therapeutics drug acquisition Phase 1/2 trial

19/03 07:03 defenseworld.net

Gilead Sciences Conference: 6-Month HIV Regimens, 12-Month PrEP, Livdelzi Expansion, Oncology Push

Gilead HIV long‑acting therapy capsid inhibitor integrase inhibitor oncology

16/03 08:34 defenseworld.net

Exelixis Highlights Zanzalintinib RCC Trials, Sequencing Debate, and December CRC PDUFA at Leerink

Exelixis Zanzalintinib RCC sequencing debate colorectal cancer PDUFA

16/03 08:34 defenseworld.net

Exelixis Highlights Zanzalintinib RCC Trials, Sequencing Debate, and December CRC PDUFA at Leerink

Exelixis Zanzalintinib RCC sequencing debate colorectal cancer PDUFA

Loading...